OBJECTIVE—We reported strong relations between serum concentrations of persistent organic pollutants (POPs), especially organochlorine (OC) pesticides or nondioxin-like polychlorinated biphenyls (PCBs), and prevalence of diabetes in a U.S population with background exposure to POPs. Here, we investigated POPs and insulin resistance, a frequent pathogenic precursor of type 2 diabetes.

RESEARCH DESIGN AND METHODS—Serum POPs and homeostasis model assessment of insulin resistance (HOMA-IR) were investigated cross-sectionally in 749 nondiabetic participants aged ≥20 years. Nineteen POPs in five subclasses were selected, detectable in ≥60% of participants.

RESULTS—Among subclasses, OC pesticides were most strongly associated with HOMA-IR. Adjusted geometric means of HOMA were 3.27, 3.36, 3.48, and 3.85 (P for trend <0.01) across quartiles of OC pesticides. The relationship strengthened with increasing HOMA-IR percentile: adjusted odds ratios comparing the highest versus lowest POPs quartile were 1.8 for being ≥50th percentile of HOMA-IR, 4.4 for being ≥75th percentile, and 7.5 for being ≥90th percentile. Associations with elevated HOMA-IR appeared to be specific to oxychlordane and trans-nonachlor but also were found for two nondioxin-like PCBs. No HOMA-IR associations were seen in the other three POP subclasses. The association between OC pesticides and HOMA-IR tended to strengthen as waist circumference increased, with no apparent association in the lowest quartile of OC pesticide concentrations.

CONCLUSIONS—These findings, coupled with those concerning diabetes prevalence, suggest that OC pesticides and nondioxin-like PCBs may be associated with type 2 diabetes risk by increasing insulin resistance, and POPs may interact with obesity to increase the risk of type 2 diabetes.

Recently, we reported striking dose-response relations between serum concentrations of persistent organic pollutants (POPs) and prevalence of diabetes in a random sample of the U.S population with background environmental exposure to POPs (1). Even though all six POPs (detectable among at least 80% of study subjects) were associated positively with diabetes, the POPs belonging to subclasses organochlorine (OC) pesticides (trans-nonachlor and oxychlordane) or nondioxin-like polychlorinated biphenyls (PCBs) (PCB153) were most strongly associated with diabetes, with odds ratios (ORs) for prevalent diabetes for those in the top decile of detectables compared with nondetectables of 11.5, 6.5, and 6.8, respectively. Furthermore, the prevalence of diabetes was quite low among subjects in the lowest category of POPs, even in subjects with BMI ≥30 kg/m2 (1), suggesting that POPs stored in adipose tissue may contribute strongly to the pathogenesis of diabetes (2,3).

Virtually all patients with type 2 diabetes are insulin resistant (4), and increased insulin resistance normally precedes the onset of diabetes by one to two decades (5,6). Thus, if the strong associations of POPs with diabetes shown in our previous study were causal, it would be reasonable to expect similar relations between POPs and insulin resistance, even in the pre-diabetic stage, as we reported for POPs and diabetes prevalence. Thus, we investigated the relation of serum concentrations of POPs with insulin resistance among nondiabetic subjects using the same dataset as in our previous study (1).

The 1999–2002 National Health and Nutrition Examination Survey (NHANES) conducted by the Centers for Disease Control and Prevention were designed to be nationally representative of the noninstitutionalized, U.S. civilian population on the basis of a complex, multistage probability sample. Details of the NHANES protocol and all testing procedures are available elsewhere (7,8). Serum concentrations of biologically important various POPs or their metabolites were measured in subsamples of the NHANES 1999–2002 surveys (9).

The NHANES standardized home interview was followed by a detailed physical examination in a mobile evaluation clinic or the participant’s home. Venous blood samples were collected and shipped weekly at −20°C. POPs were measured by high-resolution gas chromatography/high-resolution mass spectrometry using isotope dilution for quantification. All these analytes were measured in ∼5 ml of serum using a modification of the method of Turner et al. (10). The POPs were reported on a lipid-adjusted basis using concentrations of serum total cholesterol and triglycerides. Plasma glucose was measured with a hexokinase enzymatic reference method (COBAS MIRA; Roche Diagnostics, Indianapolis, IN) and serum insulin by means of a radioimmunoassay (Pharmacia Diagnostics, Uppsala, Sweden). Insulin resistance was estimated using the homeostasis model assessment (HOMA) method calculated by the following equation: (fasting insulin [mU/l] × fasting glucose [mmol/l]/22.5).

Although 49 POPs were measured in both NHANES 1999–2000 and 2001–2002, to avoid bias in estimation among those below the limit of detection (LOD), we selected the 19 POPs for which at least 60% of study subjects had concentrations more than the LOD: three polychlorinated dibenzo-p-dioxins (PCDDs), three polychlorinated dibenzofurans (PCDFs), four dioxin-like PCBs, five nondioxin-like PCBs, and four OC pesticides. There were 852 study participants aged ≥20 years with information on both fasting morning samples and serum concentrations of the 19 selected POPs. After excluding 103 subjects who had diabetes, the final sample size was 749.

For each POP, subjects with serum concentrations under the LOD were regarded as the reference group and subjects with detectable values were categorized by cutoff points of 25th, 50th, and 75th percentile values. To yield a cumulative measure of three PCDDs, we summed the ranks of the three POPs that belong to the PCDDs. The summary values were categorized by cutoff points of 25th, 50th, and 75th percentile values. We assigned and cumulated POP subclasses similarly for the three PCDFs, the four dioxin-like PCBs, the five nondioxin-like PCBs, and the four OC pesticides.

In the previous study (1), we selected the six POPs that were detected among 80% of study subjects because the selection of a true reference group with truly low levels of POPs would be very important to get valid risk estimates. As all six POPs were positively associated with diabetes, we combined the ranks of the six POPs to calculate a summary marker of six POPs. However, it would be more reasonable to summarize only POPs with similar physical and chemical properties (i.e., specific POPs belonging to the same subclasses of POPs). For this purpose, we selected 19 POPs that were detected among at least 60% of study subjects and examined the associations of POPs and HOMA of insulin resistance (HOMA-IR) within five POP subclasses. As a last step, we analyzed specific POPs belonging to those subclasses of POPs that were significantly associated with HOMA-IR.

It is important to note that subjects with serum concentrations under the LOD of a specific POP do not necessarily have zero values. They were nondetectable due to limited amounts of serum used for POP measurement. If sufficient amounts of serum were used, POPs would be detectable in almost all humans. However, as it is unlikely that the amount of serum used for POP measurement differs depending on their actual serum levels of POPs, we could assume that on average true serum concentrations of POPs among subjects with nondetectable POPs were lower than those among subjects with detectable POPs.

First, the associations of categories of POPs with HOMA were analyzed using linear regression with continuous logarithmic-transformed HOMA-IR values. Next, we assessed whether HOMA-IR differences across POP categories expanded at the higher percentiles of HOMA-IR. To do this, we estimated the OR of having HOMA-IR above a series of cut points across categories of POPs. The HOMA-IR cut points considered were the 50th percentile (≥2.34), the 75th percentile (≥3.53), and the 90th percentile (≥5.06). The use of several cutoffs allowed us to look at whether the HOMA-IR/POP association got stronger as HOMA-IR increased.

Potential confounders were age, sex, race/ethnicity, poverty income ratio, BMI, waist circumference, cigarette smoking (never, former, or current), cotinine concentrations (ng/ml), alcohol consumption (g/day), and leisure time physical activity (vigorous, moderate, or none). We substituted median values of study subjects for missing poverty income ratio, BMI, waist circumference, cotinine concentrations, or alcohol consumption in 111 subjects; exclusion of these individuals did not change any conclusions.

All statistical analyses were performed with SAS 9.1 and SUDAAN 9.0. Estimates of the main results were calculated accounting for stratification and clustering (11), adjusting for age, race and ethnicity, and poverty income ratio instead of using sample weights; this adjustment has been regarded as a good compromise between efficiency and bias (11,12). As results were very similar with SAS 9.1 and SUDAAN 9.0, we present the results based on SAS 9.1.

The sample of 749 participants included 46.3% men and 49.7% white. Mean ± SD for age was 48.2 ± 18.9 years (range 20–85). Age was the strongest and most important correlate of serum concentrations of all five subclasses of POPs with correlation coefficients from 0.46 to 0.76. After adjusting for age, there were positive pairwise correlations among serum concentrations of the five subclasses of POPs with correlation coefficients from 0.24 to 0.74. Men had low serum concentrations of PCDDs and dioxin-like PCBs. White subjects had lower concentrations of OC pesticides but higher concentrations of PCDFs or PCBs. Those with higher income had lower concentrations of OC pesticides but higher PCBs. Current smokers tended to have lower concentrations of most POPs. Alcohol consumption was associated positively with PCBs, while exercise was inversely associated with OC pesticides. OC pesticides were positively associated with BMI, while nondioxin-like PCBs showed an inverse association with BMI.

Within the whole sample, arithmetic means and SDs of fasting plasma glucose, insulin, and HOMA-IR were 95.0 ± 10.9 mg/dl, 12.0 ± 8.7 mU/l, and 2.86 ± 2.17 mU/l × mmol/l, respectively. Among five subclasses of POPs, only OC pesticides were strongly associated with HOMA-IR among these nondiabetic subjects (Table 1). Adjusted geometric means of HOMA-IR were 3.27, 3.36, 3.48, and 3.85 (P for trend <0.01) across quartiles of OC pesticides.

Table 2 shows adjusted ORs of having higher HOMA-IR associated with quartiles of five subclasses of POPs. OC pesticides were strongly associated with the increased risk for being above the 90th percentile of HOMA-IR; adjusted ORs were 1.0, 1.4, 2.9, and 7.5 (P for trend <0.01). Among other POPs, both PCDDs and nondioxin-like PCBs showed positive trends even though they failed to reach statistical significances. When we used lower cutoff points of HOMA-IR, such as 75th percentile or 50th percentile, only OC pesticides were significantly associated with HOMA-IR, but the strengths of associations tended to be weaker than those of 90th percentile. When all five subclasses of POPs were included in one model, only OC pesticides were significant.

Among four specific POPs belonging to OC pesticides, both oxychlordane and trans-nonachlor were most strongly associated with the risk of elevated HOMA-IR (Table 3). When we further investigated eight POPs belonging to nondioxin-like PCBs or PCDDs (which showed nonsignificant positive trends with the outcome of HOMA-IR ≥90th percentile), both PCB170 and PCB187 were significantly associated with HOMA-IR. On the other hand, three specific POPs (PCB153, 1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin, and 1,2,3,4,6,7,8,9-octachlorodibenzo-p-dioxin) positively associated with diabetes in a previous study (1) were not significantly associated with HOMA-IR.

In all analyses, we further considered self-reported weight loss in the 1 or 10 years before examination as possible confounders because weight loss was a strong confounder in the associations between POPs and diabetes in our previous study (13). However, the adjustment for weight loss did not change the results (data not shown).

We examined the interaction between POPs and waist circumference on the risk for insulin resistance, which was motivated by an apparent interaction between POPs and BMI on the risk of prevalent diabetes in our previous study (1). Similar to those findings, Fig. 1 shows that the association between serum concentrations of OC pesticides and the risk of higher HOMA-IR tended to be stronger as waist circumference increased even though the P for interaction was not significant (P for interaction = 0.58). Interestingly, waist circumference was not associated with elevated HOMA-IR among subjects with low concentrations of OC pesticides.

Using a cross-sectional design, the present study found serum concentrations of OC pesticides to be strongly and positively associated with insulin resistance among nondiabetic subjects. Coupled with the findings of our previous study on the associations between POPs and diabetes (1), the current results suggest that the background environmental exposure to some POPs, especially OC pesticides, may be critically involved in the pathogenesis of diabetes through a pathway involving insulin resistance. Among several OC pesticides, both oxychlordane (metabolites of chlordane) and trans-nonachlor (impurity of chlordane) were most strongly associated with insulin resistance. On the other hand, other classes of POPs, such as PCDDs, PCDF, or PCBs, were not strongly associated with insulin resistance among nondiabetic subjects. However, when specific individual POPs were examined, some POPs belonging to nondioxin-like PCBs were associated with higher values of HOMA-IR.

In our previous study on the association between POPs and diabetes (1), we reported strong dose-response relations of diabetes with all six POPs studied, which included members of the subclasses of PCDDs, nondioxin-like PCBs, and OC pesticides. Serum concentrations of most POPs in the general population are highly correlated each other. Thus, we cautioned that the six specific POPs that were strongly associated with diabetes may not be themselves causally related to diabetes, but we thought it was likely that either these six POPs or others highly correlated with them could be causally associated with diabetes (1). Although it was not stated in our previous study (1), it is interesting to note that trans-nonachlor was most strongly associated with diabetes when all six POPs studied were included in one model.

Synthesizing epidemiological findings from our previous (1,13) and current studies, we hypothesize that chlordane may be the most important POP involved in the pathogenesis of type 2 diabetes by influencing insulin resistance, although there has been no experimental study on the possible biological mechanism(s). Chlordane, a mixture of >26 compounds, was used as an agricultural pesticide on home lawns and gardens and against termites (14). Chlordane was banned in the U.S. in the1980s; however, breakdown products of chlordane still persist in the tissue of fish, birds, and mammals and are found in breast milk (15). Chlordane is rapidly metabolized in organisms into oxychlordane and γ-chlordane or into impurities such as trans-nonachlor or cis-nonachlor (14). Most studies focusing on temporal trends of POPs have identified a decreasing trend since severe restriction on POPs from 1970s to 1990s, but since 1990 the reduction of POPs was gradual (15,16). In addition, no reduction of chlordane was observed in some studies (16,17), and time trends of POPs are likely to vary for different POPs in different areas (18). Pesticides banned for over two decades in the U.S., such as chlordane or dichloro-diphenyl-trichloroethane, continue to be present at significant levels in the food supply (19).

In our previous study, subjects with very low concentrations of POPs, including those who were obese (1), surprisingly experienced a low prevalence of diabetes. This suggests that POPs contained in the adipose tissue interact with obesity in contributing to diabetes risk (2,3). Some of our previous findings may be criticized due to the cross-sectional design, but the lack of association between obesity and diabetes among subjects with very low concentrations of POPs is unlikely to be a cross-sectional bias. In this study, we observed a similar interaction pattern between OC pesticides and elevated HOMA-IR even among nondiabetic subjects. The association between serum concentration of OC pesticides and elevated HOMA-IR tended to strengthen as waist circumference increased, such that there was no association among subjects with low concentrations of OC pesticides, while waist circumference was strongly associated with HOMA-IR among subjects with high concentrations of OC pesticides. The consistency of the patterns is thought provoking, even though the formal tests for interaction were not significant; the pattern leads to our hypothesis that the toxicity of POPs related to the risk of both insulin resistance and diabetes may substantially increase as people get fatter. Additionally, they suggest (but do not prove) that obesity may not be a sufficient cause of type 2 diabetes.

Among limitations, the cross-sectional study design in the NHANES does not allow inferences regarding the temporality of events and the causality between POPs and insulin resistance. Second, misclassification bias is possible for subjects whose POPs would have been detectable with a higher sample volume. Such misclassification would be nondifferential if sample volume is unrelated to HOMA-IR. Third, HOMA-IR is a surrogate but is highly correlated with insulin resistance measured using the euglycemic-hyperinsulinemic clamp method (20). Finally, inferences should be made cautiously in light of the multiple comparisons made, even given the strong agreement between the present findings and those related to prevalent type 2 diabetes (1).

In summary, along with our previous finding on the association between POPs and diabetes, our current study raises particular suspicion that OC pesticides and nondioxin-like PCBs may be involved in the pathogenesis of insulin resistance, which may explain part of the excess risk for diabetes, associated with POPs more generally. Especially, the interaction between OC pesticides and obesity on the risk of insulin resistance and diabetes suggests that POPs stored in adipose tissue may play a role in the current epidemic of type 2 diabetes.

Figure 1—

Interaction between waist circumference and serum concentrations of OC pesticides on the prevalence of elevated HOMA-IR (top 10th percentile vs. lower values). Adjusted for age, sex, race, poverty income ratio, BMI, cigarette smoking, serum cotinine, alcohol consumption, and exercise (P for interaction = 0.58). The numbers in the table are adjusted ORs with the number at risk in each cell. *P < 0.05.

Figure 1—

Interaction between waist circumference and serum concentrations of OC pesticides on the prevalence of elevated HOMA-IR (top 10th percentile vs. lower values). Adjusted for age, sex, race, poverty income ratio, BMI, cigarette smoking, serum cotinine, alcohol consumption, and exercise (P for interaction = 0.58). The numbers in the table are adjusted ORs with the number at risk in each cell. *P < 0.05.

Close modal
Table 1—

Adjusted* geometric means and SEs of HOMA-IR by quartiles of PCDDs, PCDFs, dioxin-like PCBs, nondioxin-like PCBs, and OC pesticides

AnalyteGeometric means ± SEs of HOMA-IR
Ptrend
<25th†25th–<50th50th–<75th≥75th
PCDDs      
    Model 1 3.30 ± 0.43 3.48 ± 0.43 3.49 ± 0.42 3.68 ± 0.50 0.05 
    Model 2 3.39 ± 0.36 3.50 ± 0.35 3.47 ± 0.34 3.59 ± 0.40 0.25 
PCDFs      
    Model 1 3.45 ± 0.43 3.39 ± 0.43 3.51 ± 0.42 3.59 ± 0.46 0.46 
    Model 2 3.44 ± 0.35 3.48 ± 0.34 3.44 ± 0.34 3.58 ± 0.37 0.37 
Dioxin-like PCBs      
    Model 1 3.45 ± 0.48 3.44 ± 0.43 3.46 ± 0.42 3.59 ± 0.52 0.52 
    Model 2 3.50 ± 0.40 3.48 ± 0.35 3.42 ± 0.34 3.54 ± 0.42 0.93 
Nondioxin-like PCBs      
    Model 1 3.65 ± 0.52 3.40 ± 0.43 3.54 ± 0.44 3.36 ± 0.48 0.21 
    Model 2 3.49 ± 0.41 3.38 ± 0.35 3.50 ± 0.36 3.57 ± 0.42 0.42 
OC pesticides      
    Model 1 3.13 ± 0.45 3.30 ± 0.40 3.56 ± 0.43 4.02 ± 0.58 <0.01 
    Model 2 3.27 ± 0.39 3.36 ± 0.33 3.48 ± 0.35 3.85 ± 0.45 <0.01 
AnalyteGeometric means ± SEs of HOMA-IR
Ptrend
<25th†25th–<50th50th–<75th≥75th
PCDDs      
    Model 1 3.30 ± 0.43 3.48 ± 0.43 3.49 ± 0.42 3.68 ± 0.50 0.05 
    Model 2 3.39 ± 0.36 3.50 ± 0.35 3.47 ± 0.34 3.59 ± 0.40 0.25 
PCDFs      
    Model 1 3.45 ± 0.43 3.39 ± 0.43 3.51 ± 0.42 3.59 ± 0.46 0.46 
    Model 2 3.44 ± 0.35 3.48 ± 0.34 3.44 ± 0.34 3.58 ± 0.37 0.37 
Dioxin-like PCBs      
    Model 1 3.45 ± 0.48 3.44 ± 0.43 3.46 ± 0.42 3.59 ± 0.52 0.52 
    Model 2 3.50 ± 0.40 3.48 ± 0.35 3.42 ± 0.34 3.54 ± 0.42 0.93 
Nondioxin-like PCBs      
    Model 1 3.65 ± 0.52 3.40 ± 0.43 3.54 ± 0.44 3.36 ± 0.48 0.21 
    Model 2 3.49 ± 0.41 3.38 ± 0.35 3.50 ± 0.36 3.57 ± 0.42 0.42 
OC pesticides      
    Model 1 3.13 ± 0.45 3.30 ± 0.40 3.56 ± 0.43 4.02 ± 0.58 <0.01 
    Model 2 3.27 ± 0.39 3.36 ± 0.33 3.48 ± 0.35 3.85 ± 0.45 <0.01 
*

Model 1: Adjusted for age, sex, race, and poverty income ratio. Model 2: Additional adjustment for BMI, waist circumference, cigarette smoking, serum cotinine concentration, alcohol consumption, and exercise.

Detectable values of each POP were individually ranked, and the rank orders of the individual POPs in each subclass were summed to arrive at the subclass value. All not detectable values were ranked as zero. The summary values were categorized by cutoff points of 25th, 50th, and 75th values of the sum of ranks.

Table 2—

Adjusted* ORs and 95% CIs of prevalence of elevated HOMA-IR by quartiles of PCDDs, PCDFs, dioxin-like PCBs, nondioxin-like PCBs, and OC pesticides

Analyte<25th25th–<50th50th–<75th≥75thPtrend
>90th percentile versus lower values      
    PCDDs      
        Cases/n 13/187 18/187 17/188 26/187  
        Adjusted OR (95% CI) Referent 1.6 (0.7–3.8) 1.3 (0.5–3.3) 2.3 (0.9–6.0) 0.14 
    PCDFs      
        Cases/n 13/187 20/187 17/188 24/187  
        Adjusted OR (95% CI) Referent 1.8 (0.8–4.2) 1.2 (0.5–2.8) 1.7 (0.7–4.0) 0.46 
    Dioxin-like PCBs      
        Cases/n 15/186 20/188 17/188 22/187  
        Adjusted OR (95% CI) Referent 1.5 (0.7–3.4) 1.2 (0.5–3.1) 1.4 (0.5–4.1) 0.60 
    Nondioxin-like PCBs      
        Cases/n 18/187 14/187 19/188 23/187  
        Adjusted OR (95% CI) Referent 1.0 (0.4–2.4) 1.5 (0.6–3.7) 2.3 (0.8–6.4) 0.10 
    OC pesticides      
        Cases/n 12/187 12/188 19/187 31/187  
        Adjusted OR (95% CI) Referent 1.4 (0.5–3.6) 2.9 (1.0–8.1) 7.5 (2.3–23.9) <0.01 
>75th percentile versus lower values      
    PCDDs      
        Cases/n 45/187 43/187 44/188 55/187  
        Adjusted OR (95% CI) Referent 0.8 (0.5–1.5) 0.8 (0.4–1.5) 1.1 (0.6–2.1) 0.80 
    PCDFs      
        Cases/n 47/187 41/187 48/188 51/187  
        Adjusted OR (95% CI) Referent 0.9 (0.5–1.6) 0.9 (0.5–1.6) 1.0 (0.6–1.9) 0.89 
    Dioxin-like PCBs      
        Cases/n 47/186 47/188 38/188 55/187  
        Adjusted OR (95% CI) Referent 1.0 (0.6–1.8) 0.7 (0.4–1.4) 1.2 (0.6–2.6) 0.80 
    Nondioxin-like PCBs      
        Cases/n 51/187 40/187 47/188 49/187  
        Adjusted OR (95% CI) Referent 0.9 (0.5–1.6) 1.0 (0.5–2.0) 1.4 (0.7–3.0) 0.33 
    OC pesticides      
        Cases/n 32/187 46/188 44/187 65/187  
        Adjusted OR (95% CI) Referent 2.2 (1.1–4.2) 1.9 (0.9–3.9) 4.4 (2.0–10.1) <0.01 
>50th percentile versus lower values      
    PCDDs      
        Cases/n 86/187 96/187 99/188 94/187  
        Adjusted OR (95% CI) Referent 1.1 (0.7–1.8) 1.0 (0.6–1.8) 0.8 (0.4–1.4) 0.48 
    PCDFs      
        Cases/n 90/187 84/187 103/188 98/187  
        Adjusted OR (95% CI) Referent 0.9 (0.5–1.4) 1.2 (0.7–2.0) 1.2 (0.7–2.0) 0.37 
    Dioxin-like PCBs      
        Cases/n 87/186 92/188 98/188 98/187  
        Adjusted OR (95% CI) Referent 1.0 (0.6–1.7) 1.1 (0.6–1.9) 1.1 (0.6–2.1) 0.79 
    Nondioxin-like PCBs      
        Cases/n 98/187 81/187 105/188 91/187  
        Adjusted OR (95% CI) Referent 0.7 (0.4–1.2) 1.1 (0.6–2.0) 1.1 (0.5–2.1) 0.66 
    OC pesticides      
        Cases/n 78/187 84/188 102/187 111/187  
        Adjusted OR (95% CI) Referent 1.0 (0.6–1.7) 1.4 (0.8–2.5) 1.8 (0.9–3.6) 0.05 
Analyte<25th25th–<50th50th–<75th≥75thPtrend
>90th percentile versus lower values      
    PCDDs      
        Cases/n 13/187 18/187 17/188 26/187  
        Adjusted OR (95% CI) Referent 1.6 (0.7–3.8) 1.3 (0.5–3.3) 2.3 (0.9–6.0) 0.14 
    PCDFs      
        Cases/n 13/187 20/187 17/188 24/187  
        Adjusted OR (95% CI) Referent 1.8 (0.8–4.2) 1.2 (0.5–2.8) 1.7 (0.7–4.0) 0.46 
    Dioxin-like PCBs      
        Cases/n 15/186 20/188 17/188 22/187  
        Adjusted OR (95% CI) Referent 1.5 (0.7–3.4) 1.2 (0.5–3.1) 1.4 (0.5–4.1) 0.60 
    Nondioxin-like PCBs      
        Cases/n 18/187 14/187 19/188 23/187  
        Adjusted OR (95% CI) Referent 1.0 (0.4–2.4) 1.5 (0.6–3.7) 2.3 (0.8–6.4) 0.10 
    OC pesticides      
        Cases/n 12/187 12/188 19/187 31/187  
        Adjusted OR (95% CI) Referent 1.4 (0.5–3.6) 2.9 (1.0–8.1) 7.5 (2.3–23.9) <0.01 
>75th percentile versus lower values      
    PCDDs      
        Cases/n 45/187 43/187 44/188 55/187  
        Adjusted OR (95% CI) Referent 0.8 (0.5–1.5) 0.8 (0.4–1.5) 1.1 (0.6–2.1) 0.80 
    PCDFs      
        Cases/n 47/187 41/187 48/188 51/187  
        Adjusted OR (95% CI) Referent 0.9 (0.5–1.6) 0.9 (0.5–1.6) 1.0 (0.6–1.9) 0.89 
    Dioxin-like PCBs      
        Cases/n 47/186 47/188 38/188 55/187  
        Adjusted OR (95% CI) Referent 1.0 (0.6–1.8) 0.7 (0.4–1.4) 1.2 (0.6–2.6) 0.80 
    Nondioxin-like PCBs      
        Cases/n 51/187 40/187 47/188 49/187  
        Adjusted OR (95% CI) Referent 0.9 (0.5–1.6) 1.0 (0.5–2.0) 1.4 (0.7–3.0) 0.33 
    OC pesticides      
        Cases/n 32/187 46/188 44/187 65/187  
        Adjusted OR (95% CI) Referent 2.2 (1.1–4.2) 1.9 (0.9–3.9) 4.4 (2.0–10.1) <0.01 
>50th percentile versus lower values      
    PCDDs      
        Cases/n 86/187 96/187 99/188 94/187  
        Adjusted OR (95% CI) Referent 1.1 (0.7–1.8) 1.0 (0.6–1.8) 0.8 (0.4–1.4) 0.48 
    PCDFs      
        Cases/n 90/187 84/187 103/188 98/187  
        Adjusted OR (95% CI) Referent 0.9 (0.5–1.4) 1.2 (0.7–2.0) 1.2 (0.7–2.0) 0.37 
    Dioxin-like PCBs      
        Cases/n 87/186 92/188 98/188 98/187  
        Adjusted OR (95% CI) Referent 1.0 (0.6–1.7) 1.1 (0.6–1.9) 1.1 (0.6–2.1) 0.79 
    Nondioxin-like PCBs      
        Cases/n 98/187 81/187 105/188 91/187  
        Adjusted OR (95% CI) Referent 0.7 (0.4–1.2) 1.1 (0.6–2.0) 1.1 (0.5–2.1) 0.66 
    OC pesticides      
        Cases/n 78/187 84/188 102/187 111/187  
        Adjusted OR (95% CI) Referent 1.0 (0.6–1.7) 1.4 (0.8–2.5) 1.8 (0.9–3.6) 0.05 
*

Adjusted for age, sex, race, poverty income ratio, BMI, waist circumference, cigarette smoking, serum cotinine, alcohol consumption, and exercise.

Detectable values of each POP were individually ranked, and the rank orders of the individual POPs in each subclass were summed to arrive at the subclass value. All not detectable values were ranked as zero. The summary values were categorized by cutoff points of 25th, 50th, and 75th values of the sum of ranks.

Table 3—

Adjusted* ORs and 95% CIs of prevalence of HOMA-IR above its 90th percentile by categories of specific POPs belonging to OC pesticides, nondioxin-like PCBs, or PCDDs

AnalyteNondetectableDetectable
Ptrend
<25th25th–<50th50th–<75th≥75th
OC pesticides       
    Oxychlordane       
        Cases/n 8/140 13/154 13/151 18/151 22/153  
        Adjusted OR (95% CI) Referent 2.4 (0.8–7.0) 2.0 (0.7–6.0) 5.2 (1.6–17.4) 8.7 (2.3–33.3) <0.01 
    Trans-nonachlor       
        Cases/n 4/86 15/164 12/166 17/167 26/166  
        Adjusted OR (95% CI) Referent 2.0 (0.6–7.3) 1.6 (0.4–6.1) 2.7 (0.7–10.5) 5.4 (1.3–23.1) 0.02 
    p,p′-dichlorodiphenyltrichloroethane       
        Cases/n — 15/187 12/188 25/187 22/187  
        Adjusted OR (95% CI)  Referent 0.8 (0.3–1.9) 1.4 (0.6–3.3) 1.4 (0.5–3.7) 0.33 
    β-Hexachlorocyclohexane       
        Cases/n 15/198 14/137 15/138 9/138 21/138  
        Adjusted OR (95% CI) Referent 1.0 (0.4–2.4) 1.4 (0.5–3.6) 0.6 (0.2–1.8) 1.7 (0.6–5.1) 0.56 
Nondioxin-like PCBs       
    PCB138       
        Cases/n 20/193 9/140 10/138 19/139 16/139  
        Adjusted OR (95% CI) Referent 0.8 (0.3–2.1) 0.8 (0.3–2.1) 1.8 (0.8–4.3) 1.5 (0.6–4.0) 0.35 
    PCB153       
        Cases/n 17/155 10/147 10/150 20/149 17/148  
        Adjusted OR (95% CI) Referent 0.6 (0.3–1.6) 0.7 (0.3–1.9) 1.4 (0.5–3.5) 1.5 (0.5–4.2) 0.51 
    PCB170       
        Cases/n 20/253 10/123 15/124 14/124 15/125  
        Adjusted OR (95% CI) Referent 1.8 (0.7–4.6) 2.3 (0.9–6.1) 2.7 (0.9–7.8) 3.8 (1.2–11.5) 0.02 
    PCB180       
        Cases/n 18/179 10/142 16/143 11/143 19/142  
        Adjusted OR (95% CI) Referent 0.9 (0.4–2.2) 1.4 (0.6–3.5) 1.1 (0.4–3.3) 2.3 (0.8–7.0) 0.24 
    PCB187       
        Cases/n 22/299 9/111 15/113 10/114 18/112  
        Adjusted OR (95% CI) Referent 1.6 (0.6–4.2) 2.7 (1.0–6.9) 2.0 (0.7–5.9) 4.2 (1.5–11.7) 0.01 
PCDDs       
    1,2,3,6,7,8-hexachlorodibenzo-p-dioxin       
        Cases/n 22/198 9/138 12/137 15/139 16/137  
        Adjusted OR (95% CI) Referent 0.7 (0.3–1.7) 1.1 (0.5–2.5) 1.3 (0.6–3.1) 1.3 (0.5–3.4) 0.57 
    1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin       
        Cases/n 6/103 11/161 20/162 14/162 23/161  
        Adjusted OR (95% CI) Referent 1.3 (0.4–4.2) 2.5 (0.8–7.5) 1.5 (0.5–4.8) 2.0 (0.6–6.4) 0.30 
    1,2,3,4,6,7,8,9-octachlorodibenzo-p-dioxin       
        Cases/n 14/178 13/142 15/143 16/143 16/143  
        Adjusted OR (95% CI) Referent 1.2 (0.5–2.9) 1.5 (0.6–3.6) 1.4 (0.5–3.5) 1.3 (0.5–3.5) 0.53 
AnalyteNondetectableDetectable
Ptrend
<25th25th–<50th50th–<75th≥75th
OC pesticides       
    Oxychlordane       
        Cases/n 8/140 13/154 13/151 18/151 22/153  
        Adjusted OR (95% CI) Referent 2.4 (0.8–7.0) 2.0 (0.7–6.0) 5.2 (1.6–17.4) 8.7 (2.3–33.3) <0.01 
    Trans-nonachlor       
        Cases/n 4/86 15/164 12/166 17/167 26/166  
        Adjusted OR (95% CI) Referent 2.0 (0.6–7.3) 1.6 (0.4–6.1) 2.7 (0.7–10.5) 5.4 (1.3–23.1) 0.02 
    p,p′-dichlorodiphenyltrichloroethane       
        Cases/n — 15/187 12/188 25/187 22/187  
        Adjusted OR (95% CI)  Referent 0.8 (0.3–1.9) 1.4 (0.6–3.3) 1.4 (0.5–3.7) 0.33 
    β-Hexachlorocyclohexane       
        Cases/n 15/198 14/137 15/138 9/138 21/138  
        Adjusted OR (95% CI) Referent 1.0 (0.4–2.4) 1.4 (0.5–3.6) 0.6 (0.2–1.8) 1.7 (0.6–5.1) 0.56 
Nondioxin-like PCBs       
    PCB138       
        Cases/n 20/193 9/140 10/138 19/139 16/139  
        Adjusted OR (95% CI) Referent 0.8 (0.3–2.1) 0.8 (0.3–2.1) 1.8 (0.8–4.3) 1.5 (0.6–4.0) 0.35 
    PCB153       
        Cases/n 17/155 10/147 10/150 20/149 17/148  
        Adjusted OR (95% CI) Referent 0.6 (0.3–1.6) 0.7 (0.3–1.9) 1.4 (0.5–3.5) 1.5 (0.5–4.2) 0.51 
    PCB170       
        Cases/n 20/253 10/123 15/124 14/124 15/125  
        Adjusted OR (95% CI) Referent 1.8 (0.7–4.6) 2.3 (0.9–6.1) 2.7 (0.9–7.8) 3.8 (1.2–11.5) 0.02 
    PCB180       
        Cases/n 18/179 10/142 16/143 11/143 19/142  
        Adjusted OR (95% CI) Referent 0.9 (0.4–2.2) 1.4 (0.6–3.5) 1.1 (0.4–3.3) 2.3 (0.8–7.0) 0.24 
    PCB187       
        Cases/n 22/299 9/111 15/113 10/114 18/112  
        Adjusted OR (95% CI) Referent 1.6 (0.6–4.2) 2.7 (1.0–6.9) 2.0 (0.7–5.9) 4.2 (1.5–11.7) 0.01 
PCDDs       
    1,2,3,6,7,8-hexachlorodibenzo-p-dioxin       
        Cases/n 22/198 9/138 12/137 15/139 16/137  
        Adjusted OR (95% CI) Referent 0.7 (0.3–1.7) 1.1 (0.5–2.5) 1.3 (0.6–3.1) 1.3 (0.5–3.4) 0.57 
    1,2,3,4,6,7,8-heptachlorodibenzo-p-dioxin       
        Cases/n 6/103 11/161 20/162 14/162 23/161  
        Adjusted OR (95% CI) Referent 1.3 (0.4–4.2) 2.5 (0.8–7.5) 1.5 (0.5–4.8) 2.0 (0.6–6.4) 0.30 
    1,2,3,4,6,7,8,9-octachlorodibenzo-p-dioxin       
        Cases/n 14/178 13/142 15/143 16/143 16/143  
        Adjusted OR (95% CI) Referent 1.2 (0.5–2.9) 1.5 (0.6–3.6) 1.4 (0.5–3.5) 1.3 (0.5–3.5) 0.53 
*

Adjusted for age, sex, race, poverty income ratio, BMI, waist circumference, cigarette smoking, serum cotinine, alcohol consumption, and exercise.

Detectable values of each POP were individually ranked, and the rank orders of the individual POPs in each subclass were summed to arrive at the subclass value. All not detectable values were ranked as zero. The summary values were categorized by cutoff points of 25th, 50th, and 75th values of the sum of ranks.

This study was partly supported by the Brain Korea 21 Project in 2006 and the Korea Science and Engineering Foundation through the NRL Program (grant 2006-00562).

1.
Lee DH, Lee IK, Song KE, Steffes M, Toscano W, Baker BA, Jacobs DR Jr: A Strong dose-response relation between serum concentrations of persistent organic pollutants and diabetes: results from the National Health and Examination Survey.
Diabetes Care
29
:
1638
–1644,
2006
2.
Porta M: Persistent organic pollutants and the burden of diabetes.
Lancet
368
:
558
–559,
2006
3.
Lee DH, Jacobs DR, Porta M: Could low level background exposure to persistent organic pollutants contribute to the social burden of type 2 diabetes?
J Epidemiol Community Health
60
:
1006
–1008,
2006
4.
DeFronzo RA: Pathogenesis of type 2 diabetes mellitus.
Med Clin North Am
188
:
787
–835,
2004
5.
Lillioja S, Mott DM, Spraul M, Ferraro R, Foley JE, Ravussin E, Knowler WC, Bennett PH, Bogardus C: Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians.
N Engl J Med
329
:
1988
–1992,
1993
6.
Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR: Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offsprings of diabetic parents.
Ann Intern Med
113
:
909
–915,
1990
7.
NHANES 1999–2000 public data release file documentation [article online],
2005
. Available from http://www.cdc.gov/nchs/about/major/nhanes/nhanes99-00.htm. Accessed 28 February 2006
8.
NHANES 2000–2001 public data release file documentation [article online],
2005
. Available from http://www.cdc.gov/nchs/about/major/nhanes/nhanes01-02.htm. Accessed 28 February 2006
9.
Third national report on human exposure to environmental chemicals [article online],
2005
. Available from http://www.cdc.gov/exposurereport/3rd/pdf/thirdreport.pdf. Accessed 28 February 2006
10.
Turner W, DiPietro E, Lapeza C, Green V, Gill J, Patterson DG Jr: A fast universal automated cleanup system for the isotope-dilution HRMS analysis of PCDDs, PCDFs, coplanar PCBs, PCB congeners, and persistent pesticides from the same serum sample.
Organohalogen Comp
31
:
26
–31,
1997
11.
Korn EL, Graubard BI: Epidemiologic studies utilizing surveys: accounting for the sampling design.
Am J Public Health
81
:
1166
–1173,
1991
12.
Graubard BI, Korn EL: Analyzing health surveys for cancer-related objectives.
J Natl Cancer Inst
91
:
1005
–1016,
1999
13.
Lee DH, Jacobs DR: The nature of the relationship between prevalence of diabetes and persistent organic pollutants (Letter).
Diabetes Care
29
:
2568
,
2006
14.
Nomeir AA, Hajjar NP: Metabolism of chlordane in mammals.
Rev Environ Contam Toxicol
100
:
1
–22,
1987
15.
Sonawane BR: Chemical contaminants in human milk: an overview.
Environ Health Perspect
103
:
197
–205,
1995
16.
Konishi Y, Kuwabara K, Hori S: Continuous surveillance of organochlorine compounds in human breast milk from 1972 to 1998 in Osaka, Japan.
Arch Environ Contam Toxicol
40
:
571
–578,
2001
17.
Dallaire F, Dewailly E, Muckle G, Ayotte P: Time trends of persistent organic pollutants and heavy metals in umbilical cord blood of Inuit infants born in Nunavik (Quebec, Canada) between 1994 and 2001.
Environ Health Perspect
111
:
1660
–1664,
2003
18.
Solomon GM, Weiss PM: Chemical contaminants in breast milk: time trends and regional variability.
Environ Health Perspect
110
:
339
–347,
2002
19.
Dougherty CP, Henricks Holtz S, Reinert JC, Panyacosit L, Axelrad DA, Woodruff TJ: Dietary exposures to food contaminants across the United States.
Environ Res
84
:
170
–185,
2000
20.
Matthews DR, Hosker JP, Rudenski AS, Naylor BA, Treacher DF, Turner RC: Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.
Diabetologia
28
:
412
–419,
1985

A table elsewhere in this issue shows conventional and Système International (SI) units and conversion factors for many substances.

The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked “advertisement” in accordance with 18 U.S.C Section 1734 solely to indicate this fact.